Supercomputer Modeling of Dual-Site Acetylcholinesterase (AChE) Inhibition
DOI:
https://doi.org/10.14529/jsfi180410Abstract
Molecular docking is one of the most popular tools of molecular modeling. However, in certain cases, like development of inhibitors of cholinesterases as therapeutic agents for Alzheimer's disease, there are many aspects, which should be taken into account to achieve accurate docking results. For simple molecular docking with popular software and standard protocols, a personal computer is sucient, however quite often the results are irrelevant. Due to the complex biochemistry and biophysics of cholinesterases, computational research should be supported with quantum mechanics (QM) and molecular dynamics (MD) calculations, what requires the use of supercomputers. Experimental studies of inhibition kinetics can discriminate between dierent types of inhibition—competitive, non-competitive or mixed type—that is quite helpful for assessment of the docking results. Here we consider inhibition of human acetylcholinesterase (AChE) by the conjugate of MB and 2,8-dimethyl-tetrahydro-y-carboline, study its interactions with AChE in relation to the experimental data, and use it as an example to elucidate crucial points for reliable docking studies of bulky AChE inhibitors. Molecular docking results were found to be extremely sensitive to the choice of the X-ray AChE structure for the docking target and the scheme selected for the distribution of partial atomic charges. It was demonstrated that exible docking should be used with an additional caution, because certain protein conformational changes might not correspond with available X-ray and MD data.
References
Bachurin, S.O., Makhaeva, G.F., Shevtsova, E.F., Boltneva, N.P., Kovaleva, N.V., Lushchekina, S.V., Rudakova, E.V., Dubova, L.G., Vinogradova, D.V., Sokolov, V.B., Aksinenko, A.Y., Richardson, R.J., Aliev, G.: Conjugates of methylene blue with g-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases. Sci Rep in press (2019)
Chen, Y.C.: Beware of docking! Trends Pharmacol Sci 36(2), 78–95 (2015), DOI: 10.1016/j.tips.2014.12.001
Cheung, J., Rudolph, M.J., Burshteyn, F., Cassidy, M.S., Gary, E.N., Love, J., Franklin, M.C., Height, J.J.: Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 55(22), 10282–10286 (2012), DOI: 10.1021/jm300871x
Cho, A.E., Guallar, V., Berne, B.J., Friesner, R.: Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (qm/mm) approach. J Comp Chem 26(9), 915–931 (2005), DOI: 10.1002/jcc.20222
Hawkins, P.C., Skillman, A.G., Warren, G.L., Ellingson, B.A., Stahl, M.T.: Conformer generation with omega: algorithm and validation using high quality structures from the protein databank and cambridge structural database. J Chem Inf Model 50(4), 572–584 (2010), DOI: 10.1021/ci100031x
Kharlamova, A.D., Lushchekina, S.V., Petrov, K.A., Kots, E.D., Nachon, F., Villard-Wandhammer, M., Zueva, I.V., Krejci, E., Reznik, V.S., Zobov, V.V., Nikolsky, E.E., Masson, P.: Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment. Biochem J 473(9), 1225–1236 (2016), DOI: 10.1042/BCJ20160084
Masson, P., Lushchekina, S.V.: Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance. Arch Biochem Biophys 593, 60–68 (2016), DOI: 10.1016/j.abb.2016.02.010
Morris, G.M., Huey, R., Lindstrom, W., Sanner, M.F., Belew, R.K., Goodsell, D.S., Olson, A.J.: Autodock4 and autodocktools4: Automated docking with selective receptor exibility. J Comput Chem 30(16), 2785–2791 (2009), DOI: 10.1002/jcc.21256
Mufson, E.J., Counts, S.E., Perez, S.E., Ginsberg, S.D.: Cholinergic system during the progression of alzheimer's disease: therapeutic implications. Expert Rev Neurother 8(11), 1703–1718 (2008), DOI: 10.1586/14737175.8.11.1703
Rouleau, J., Iorga, B.I., Guillou, C.: New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid beta aggregation. Eur J Med Chem 46(6), 2193–2205 (2011), DOI: 10.1016/j.ejmech.2011.02.073
Schmidt, M.W., Baldridge, K.K., Boatz, J.A., Elbert, S.T., Gordon, M.S., Jensen, J.H., Koseki, S., Matsunaga, N., Nguyen, K.A., Su, S.J., Windus, T.L., Dupuis, M., Montgomery, J.A.: General atomic and molecular electronic-structure system. J Comp Chem 14(11), 1347–1363 (1993), DOI: 10.1002/jcc.540141112
Semenov, V.E., Zueva, I.V., Mukhamedyarov, M.A., Lushchekina, S.V., Kharlamova, A.D., Petukhova, E.O., Mikhailov, A.S., Podyachev, S.N., Saina, L.F., Petrov, K.A., Minnekhanova, O.A., Zobov, V.V., Nikolsky, E.E., Masson, P., Reznik, V.S.: 6-methyluracil derivatives as bifunctional acetylcholinesterase inhibitors for the treatment of alzheimer's disease. ChemMedChem 10(11), 1863–1874 (2015), DOI: 10.1002/cmdc.201500334
Sherman, W., Day, T., Jacobson, M.P., Friesner, R.A., Farid, R.: Novel procedure for modeling ligand/receptor induced t eects. J Med Chem 49(2), 534–553 (2006), DOI: 10.1021/jm050540c
Sokolov, V.B., Aksinenko, A.Y., Epishina, T.A., Goreva, T.V., Grigoriev, V.V., Gabrel'yan, A.V., Bachurin, S.O.: Synthesis and biological activity of n-substituted tetrahydro-g-carbolins bearing bis(dimethylamino)phenothiazine moiety. Russ Chem Bull 64(3), 718–722 (2015), DOI: 10.1007/s11172-015-0925-3
Varfolomeev, S.D., Lushchekina, S.V., Nemukhin, A.V., Kulakova, A.M., Kots, E.D., Makhaeva, G.F., Delacour, H., Lockridge, O., Masson, P.: Molecular polymorphism of human enzymes as the basis of individual sensitivity to drugs. supercomputer-assisted modeling as a tool for analysis of structural changes and enzymatic activity of proteins. Russ Chem Bull 65(6), 1592–1607 (2017), DOI: 10.1007/s11172-016-1487-8
Yu, H.S., Watson, M.A., Bochevarov, A.D.: Weighted averaging scheme and local atomic descriptor for pka prediction based on density functional theory. J Chem Inf Model 58(2), 271–286 (2018), DOI: 10.1021/acs.jcim.7b00537
Zueva, I.V., Lushchekina, S.V., Masson, P.: Water structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesterase. Biosci Rep 38(3), BSR20180609 (2018), DOI: 10.1042/BSR20180609
Downloads
Published
How to Cite
Issue
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-Non Commercial 3.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.